Parry DM - Search Results

1

Chordoma: incidence and survival patterns in the United States, 1973-1995.

McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. McMaster ML, et al. Among authors: parry dm. Cancer Causes Control. 2001 Jan;12(1):1-11. doi: 10.1023/a:1008947301735. Cancer Causes Control. 2001. PMID: 11227920

2

T (brachyury) gene duplication confers major susceptibility to familial chordoma.

Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ. Yang XR, et al. Among authors: parry dm. Nat Genet. 2009 Nov;41(11):1176-8. doi: 10.1038/ng.454. Epub 2009 Oct 4. Nat Genet. 2009. PMID: 19801981 Free PMC article.

3

Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs).

Yang X', Beerman M, Bergen AW, Parry DM, Sheridan E, Liebsch NJ, Kelley MJ, Chanock S, Goldstein AM. Yang X', et al. Among authors: parry dm. Int J Cancer. 2005 Sep 1;116(3):487-91. doi: 10.1002/ijc.21006. Int J Cancer. 2005. PMID: 15818627

4

Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population.

McMaster ML, Goldstein AM, Parry DM. McMaster ML, et al. Among authors: parry dm. J Med Genet. 2011 Jul;48(7):444-9. doi: 10.1136/jmg.2010.085092. Epub 2011 Jan 25. J Med Genet. 2011. PMID: 21266383 Free PMC article.

5

Strategies for controlling cancer through genetics.

Parry DM, Mulvihill JJ, Miller RW, Berg K, Carter CL. Parry DM, et al. Cancer Res. 1987 Dec 15;47(24 Pt 1):6814-7. Cancer Res. 1987. PMID: 3315192 Review. No abstract available.

6

Survival after retinoblastoma: long-term consequences and family history of cancer.

Byrne J, Fears TR, Whitney C, Parry DM. Byrne J, et al. Among authors: parry dm. Med Pediatr Oncol. 1995 Mar;24(3):160-5. doi: 10.1002/mpo.2950240304. Med Pediatr Oncol. 1995. PMID: 7838037

7

Relationship between head circumference and height in normal adults and in the nevoid basal cell carcinoma syndrome and neurofibromatosis type I.

Bale SJ, Amos CI, Parry DM, Bale AE. Bale SJ, et al. Among authors: parry dm. Am J Med Genet. 1991 Aug 1;40(2):206-10. doi: 10.1002/ajmg.1320400217. Am J Med Genet. 1991. PMID: 1910262

8

Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.

Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Parry DM, et al. Am J Med Genet. 1994 Oct 1;52(4):450-61. doi: 10.1002/ajmg.1320520411. Am J Med Genet. 1994. PMID: 7747758

9

Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications.

Andersson HC, Parry DM, Mulvihill JJ. Andersson HC, et al. Among authors: parry dm. Am J Med Genet. 1995 Mar 13;56(1):72-5. doi: 10.1002/ajmg.1320560116. Am J Med Genet. 1995. PMID: 7747790 Review.

10

In vitro radiosensitivity of fibroblasts from thyroid and skin cancer patients treated with X-rays for tinea capitis.

Ron E, Tarone RE, Modan B, Chaki R, Alfandary E, Parry DM, Makar M, Setlow N, Mulvihill JJ, Miller RW, et al. Ron E, et al. Among authors: parry dm. Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):229-32. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8019372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results